Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-11 10:14 am Purchase | 2025-12-31 | 13G | Origin Materials, Inc. ORGN | Ayrton Capital LLC | 16,992,123 9.990% | 16,992,123 (New Position) | Filing History |
| 2026-02-11 10:10 am Purchase | 2025-12-31 | 13G | Nvni Group Limited Ordinary Shares NVNI | Ayrton Capital LLC | 1,114,498 9.990% | 1,114,498 (New Position) | Filing History |
| 2026-02-11 10:09 am Purchase | 2025-12-31 | 13G | MultiSensor AI Holdings, Inc. MSAI | Ayrton Capital LLC | 5,602,028 9.990% | 5,602,028 (New Position) | Filing History |
| 2026-02-11 10:05 am Purchase | 2025-12-31 | 13G | GeoVax Labs, Inc. GOVX | Ayrton Capital LLC | 4,810,451 9.990% | 4,810,451 (New Position) | Filing History |
| 2026-02-11 10:05 am Purchase | 2025-12-31 | 13G | Genprex, Inc. GNPX | Ayrton Capital LLC | 249,788 9.720% | 249,788 (New Position) | Filing History |
| 2026-02-11 10:02 am Sale | 2025-12-31 | 13G | Co-Diagnostics, Inc. CODX | Ayrton Capital LLC | 0 0.000% | -124,611 (Position Closed) | Filing History |
| 2026-02-11 10:00 am Unchanged | 2025-12-31 | 13G | CleanCore Solutions, Inc. ZONE | Ayrton Capital LLC | 750,000 0.370% | 0 (Unchanged) | Filing History |
| 2026-02-11 09:57 am Purchase | 2025-12-31 | 13G | C3is Inc. CISS | Ayrton Capital LLC | 856,228 9.990% | 856,228 (New Position) | Filing History |
| 2026-02-11 09:56 am Purchase | 2025-12-31 | 13G | Ascent Solar Technologies, Inc. Common Stock ASTI | Ayrton Capital LLC | 494,979 9.990% | 494,979 (New Position) | Filing History |
| 2026-02-11 09:51 am Purchase | 2025-12-31 | 13G | Apimeds Pharmaceuticals US, Inc APUS | Ayrton Capital LLC | 1,397,021 9.990% | 1,397,021 (New Position) | Filing History |
| 2026-02-11 09:44 am Sale | 2025-12-31 | 13G | Traws Pharma, Inc. TRAW | Ayrton Capital LLC | 342,935 4.290% | -60,715 (-15.04%) | Filing History |
| 2026-02-11 09:38 am Purchase | 2025-12-31 | 13G | Envoy Medical, Inc. COCH | Ayrton Capital LLC | 2,457,963 7.870% | 2,457,963 (New Position) | Filing History |
| 2025-11-13 3:57 pm Purchase | 2025-09-30 | 13G | China Natural Resources, Inc. CHNR | Ayrton Capital LLC | 69,743 0.800% | 61,025 (+699.99%) | Filing History |
| 2025-11-13 3:51 pm Sale | 2025-09-30 | 13G | Nano Labs Ltd NA | Ayrton Capital LLC | 952,381 4.400% | -590,548 (-38.27%) | Filing History |
| 2025-11-13 3:49 pm Purchase | 2025-09-30 | 13G | 60 Degrees Pharmaceuticals, Inc. SXTP | Ayrton Capital LLC | 44,357 4.140% | 3,487 (+8.53%) | Filing History |
| 2025-11-13 3:44 pm Purchase | 2025-09-30 | 13G | LM Funding America, Inc. LMFA | Ayrton Capital LLC | 1,606,046 9.990% | 1,606,046 (New Position) | Filing History |
| 2025-11-13 3:42 pm Purchase | 2025-09-30 | 13G | Enveric Biosciences, Inc. ENVB | Ayrton Capital LLC | 658,465 9.990% | 658,465 (New Position) | Filing History |
| 2025-11-13 3:41 pm Purchase | 2025-09-30 | 13G | DEFSEC Technologies Inc. DFSC | Ayrton Capital LLC | 102,907 6.120% | 102,907 (New Position) | Filing History |
| 2025-11-13 3:39 pm Purchase | 2025-09-30 | 13G | Co-Diagnostics, Inc. CODX | Ayrton Capital LLC | 124,611 9.700% | 124,611 (New Position) | Filing History |
| 2025-11-13 3:36 pm Purchase | 2025-09-30 | 13G | CleanCore Solutions, Inc. ZONE | Ayrton Capital LLC | 750,000 5.450% | 750,000 (New Position) | Filing History |